Increased expression of poly(ADP-ribose) polymerase-1 contributes to caspase-independent myocyte cell death during heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 2 57-2, 2005, Pages

  Pillai, Jyothish B ^a   Russell, Hyde M ^a   Raman, Jai ^a   Jeevanandam, Valluvan ^a   Gupta, Mahesh P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Hypertrophy; Myocyte cell death

Indexed keywords

CASPASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FORCED SWIMMING TEST; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HEART DILATATION; HEART FAILURE; HEART MUSCLE CELL; HEART TRANSPLANTATION; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CARDIOMEGALY; CASPASES; CELL DEATH; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART FAILURE, CONGESTIVE; HUMANS; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MYOCYTES, CARDIAC; POLY(ADP-RIBOSE) POLYMERASES;

EID: 12344289049     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00437.2004     Document Type: Article

References (50)

1. Barrans JD, Allen PD, Stamatiou D, Dzau VJ, and Liew CC. Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular based cDNA microarray. Am J Pathol 160: 2035-2043, 2002.
2. Bartunek J, Vanderheyden M, Knaapen MWM, Tack W, Kockx MM, and Goethals M. DNA damage/repair proteins are elevated in the failing human myocardium due to idiopathic dilated cardiomyopathy. J Am Coll Cardiol 40: 1097-1103, 2002.
3. Burkart V, Wang ZQ, Radons J, Heller B, Herceg Z, Stingl L, Wagner EF, and Kolb H. Mice lacking the poly (ADP-ribose) polymerase gene are resistance to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat Med 5: 314-319, 1999.
4. Butler AJ and Ordahl CP. Poly (ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription. Mol Cell Biol 19: 296-306, 1999.
5. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P, Bronson R, Appella E, Alt FW, and Chua KF. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 100: 10794-10799, 2003.
6. Chiarugi A. Poly(ADP-ribose) polymerase: killer or conspirator? The "suicide hypothesis" revisited. Trends Pharmacol Sci 23: 122-129, 2002.
7. Clerk A, Cole SM, Cullingford TE, Harrison JG, Jormakka M, and Valks DM. Regulation of cardiac myocyte cell death. Pharmacol Ther 97: 223-261, 2003.
8. Condorelli G, Morisco C, Stassi G, Notte A, Fraina F, Sgaramella G, DeRienzo A, Roncarati Trimarco B, and Lembo G. Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptitic genes bax and bcl-2 during left ventricular adaptation to chronic pressure overload. Circulation 99: 3071-3078, 1999.
9. Davis FJ, Gupta M, Pogwizd SM, Bacha E, Jeevanandam V, and Gupta MP. Increased expression of alternatively spliced dominant negative isoform of SRF in human failing hearts. Am J Physiol Heart Circ Physiol 282: H1521-H1533, 2002.
10. DeBoer RA, Veldhuisen DJV, Wijk JVD, Brouwer R, Jonge ND, Cole GM, and Suurmeijer AJH. Additional use of immunostaining for active caspase3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure. J Card Fail 6: 330-337, 2000.
11. Du L, Zhang X, Han YY, Burke NA, Kochanek PM, Watkins SC, Graham SH, Carcillo JA, Szabo C, and Clark RSB. Intra-mitrochondrial poly (ADP-ribosylation) contributes to NAD depletion and cell death induced by oxidative stress. J Biol Chem 278: 18426-18433, 2003.
12. Elsasser A, Suzuki K, and Schaper J. Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure. J Mol Cell Cardiol 32: 711-724, 2000.
13. Emmanuel T, Than-Vinh D, Lucie R, Claudine W, Bun-Seng T, Louis G, Johanne T, Ketty S, and Pavel H. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest 97: 2891-2897, 1996.
14. Frey N, Katus HA, Olson EN, and Hill JA. Hypertrophy of the heart: a new therapeutic target. Circulation 109: 1580-1589, 2004.
15. Guerra S, Leri A, Wang X, Finato N, Di Loreto C, Beltrami CA, Kajstura J, and Anversa P. Myocyte death in the failing human heart is gender dependent. Circ Res 85: 856-866, 1999.
16. Gupta MP, Amin CS, Gupta M, Hay N, and Zak M. Transcription enhancer factor 1 interacts with a basic helix-loop-helix zipper protein, Max, for positive regulation of the cardiac α-myosin heavy-chain gene expression. Mol Cell Biol 17: 3924-3936, 1997.
17. Ha HC and Snyder SH. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 69: 13978-13982, 1999.
18. Hassa PO, Buerki C, Lombardi C, Imhof R, and Hottiger MO. Transcriptional coactivation of nuclear factor-κB-dependent gene expression by p300 is regulated by poly (ADP)-ribose polymerase-1. J Biol Chem 278: 45145-45153, 2003.
19. Hein S, Aron E, Kostin S, Schönburg M, Elsässer A, Polyakova V, Bauer EP, Klövekorn WP, and Schaper J. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart. Circulation 107: 984-991, 2003.
20. Homburg S, Visochek L, Moran N, Dantzer F, Priel E, Asculai E, Schwartz D, Rotter V, Dekel N, and Cohen-Armon M. A fast signal-induced activation of poly (ADP) ribose polymerase: a novel downstream target of phospholipase-C. J Cell Biol 150: 293-307, 2000.
21. Jeggo PA. DNA repair: PARP-another guardian angel. Curr Biol 8: R49-R51, 1998.
22. Kang PM and Izumo S. Apoptosis and heart failure: a critical review of the literature. Circ Res 86: 1107-1113, 2000.
23. Kang PM, Yue P, Liu Z, Tarnavski O, Bodyak N, and Izumo S. Alterations in apoptosis regulatory factors during hypertrophy and heart failure. Am J Physiol Heart Circ Physiol 287: H72-H80, 2004.
24. Kannan P, Yu Y, Wankhade S, and Tainsky MA. Poly ADP-ribose polymerase is a coactivator for AP-2-mediated transcriptional activation. Nucleic Acids Res 27: 866-874, 1999.
25. Kaplan ML, Cheslow Y, Vikstrom K, Malhotra A, Geenen D, Nakouzi A, Leinwand LA, and Buttrick PM. Cardiac adaptations to chronic exercise in mice. Am J Physiol Heart Circ Physiol 267: H1167-H1173, 1994.
26. Knanpen MWM, Davies MJ, DeBei M, Haven AJ, Martinet W, and Kockx MM. Apoptotic versus autophagic cell death in heart failure. Cardiovasc Res 51: 304-31, 2001.
27. Koda M, Takemura G, Kanoh M, Hayakawa K, Kawase Y, Maruyama R, Li Y, Minatoguchi S, Fujiwara T, and Fujiwara H. Myocytes positive for in situ markers for DNA breaks in human hearts which are hypertrophic, but neither failed nor dilated: a manifestation of cardiac hypertrophy rather than failure. J Pathol 199: 229-236, 2003.
28. Kraus WL and Lis JT. PARP goes transcription. Cell 113: 677-683, 2003.
29. 3 and ATP. Biochemistry 43: 210-216, 2004.
30. Liaudet L, Soriano FG, Szabo E, Virag L, Mabley JG, Salzman AL, and Szabo C. Protection against hemorrhagic shock in mice genetically deficient in poly (ADP ribose) polymerase. Proc Natl Acad Sci USA 97: 10203-10208, 2000.
31. Meguro T, Hong C, Asai K, Takagi G, Mckinsey TA, Olson E, and Vatner S. Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure. Circ Res 84: 735-740, 1999.
32. Meisterernst M, Stelzer G, and Roeder RG. Poly(ADP-ribose) polymerase enhances activator-dependent transcription in vitro. Proc Natl Acad Sci USA 94: 2261-2265, 1997.
33. Oei SL, Griesenbeck J, Schweiger M, Babich V, Kropotov A, and Tomilin N. Interaction of the transcription factor YY1 with human poly (ADP-ribose) transferase. Biochem Biophys Res Commun 240: 108-111, 1997.
34. Ogura T, Takenouchi N, Yamaguchi M, Matsukage A, Sugimura T, and Esumi H. Striking similarity of the distribution patterns of the poly (ADP-ribose) polymerase and DNA polymerase β among various mouse organs. Biochem Biophys Res Commun 172: 377-384, 1990.
35. Poirier GG, de Murcia G, Jongstra-Bilen J, Niedergang C, and Mandel P. Poly (ADP ribosyl)ation of polynucleosomes causes relaxation of chromatin structure. Proc Natl Acad Sci USA 79: 3423-3427, 1982.
36. Purcell NH and Molkentin JD. Is nuclear factor kappaB an attractive therapeutic target for treating cardiac hypertrophy? Circulation 108: 638-640, 2003.
37. Sakamoto J, Miura T, Shimamoto K, and Horio Y. Predominant expression of Sir2α, an NAD-dependent histone deacetrylase, in the embryonic mouse heart and brain. FEBS Lett 556: 281-286, 2004.
38. Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, and Colucci WS. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 34: 379-388, 2002.
39. Simbulan-Rosenthal CM, Ly DH, Rosenthal DS, Konopka G, Luo RB, Wang ZQ, Schultz PG, and Smulson ME. Misregulation of gene expression in primary flbroblasts lacking poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 97: 11274-11279, 2000.
40. Sucharov CC, Mariner P, Long C, Bristow M, and Leinwand L. Yin Yang 1 is increased in human heart failure and represses the activity of the human alpha-myosin heavy chain promoter. J Biol Chem 278: 31233-31239, 2003.
41. Thiemermann C, Bowes J, Myint FP, and Vane JR. Inhibition of the activity of of poly (ADP-ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc Natl Acad Sci USA 94: 679-683, 1997.
42. Tissenbaum UA and Guarente L. Increased dosage of a Sir-2 gene extends lifespan in C. elegans. Nature 410: 227-230, 2001.
43. Tulin A and Spradling A. Chromatin loosening by poly (ADP)-ribose polymerase at Drosophila puff loci. Science 299: 560-562, 2003.
44. Vaziri H, Dessain SK, Ng E, Imai SI, Frye RA, Pandita TK, Guarente L, and Weinberg RA. hSIR2 (SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159, 2001.
45. Virag L and Szabo C. The therapeutic potential of PARP-inhibitors. Pharmacol Rev 54: 375-429, 2002.
46. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, and Dawson VL. Mediation of PARP-dependent cell death by apoptosis-inducing factor. Science 297: 259-263, 2002.
47. Yun SJ, Lee DK, Kim MO, Jung B, Kim SO, Sohn NW, and Lee EH. Reduction but not cleavage of PARP during stress-mediated cell-death in the rat hippocampus. Mol Neurosci 14: 935-939, 2003.
48. Ziegler M and Oei SL. A cellular survival switch: poly(ADP-ribosyl)ation stimulates DNA repair and silences transcription. Bioessays 23: 543-548, 2001.
49. Zhang J. Are poly(ADP-ribosylation) by PARP-1 and deacetylation by SIR2 linked? Bioessays 25: 808-814, 2003.
50. Zingarelli B, Hake PW, O'Connor M, Denenberg A, Wong HR, Kong S, and Aronow BJ. Differential regulation of activator protein-1 and heat shock factor-1 in myocardial ischemia and reperfusion injury: role of poly (ADP-ribose) polymerase-1. Am J Physiol Heart Circ Physiol 286: H1408-H1415, 2004.